Statements (54)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:neurodegenerative_diseases
|
| gptkbp:affects |
motor symptoms
non-motor symptoms functional decline individuals under 50 |
| gptkbp:associated_with |
environmental factors
genetic factors |
| gptkbp:clinical_trial |
ongoing research
new therapies experimental treatments |
| gptkbp:community |
support groups
advocacy organizations |
| gptkbp:complications |
gptkb:depression
anxiety cognitive decline |
| gptkbp:diagnosis |
clinical evaluation
neurological examination |
| gptkbp:future_prospects |
understanding pathophysiology
enhancing patient care developing personalized medicine |
| https://www.w3.org/2000/01/rdf-schema#label |
young onset Parkinson's
|
| gptkbp:impact |
quality of life
|
| gptkbp:influenced_by |
gptkb:Coca-Cola
gptkb:exercise stress management |
| gptkbp:is_a_resource_for |
gptkb:educational_materials
local events online forums |
| gptkbp:player_development |
varies by individual
|
| gptkbp:prevalence |
less common than late-onset Parkinson's
|
| gptkbp:public_awareness |
research funding
public education symptom recognition |
| gptkbp:research_focus |
biomarkers
treatment options patient support |
| gptkbp:risk_factor |
family history
head trauma exposure to toxins |
| gptkbp:support |
family involvement
peer support professional counseling |
| gptkbp:symptoms |
stiffness
tremors bradykinesia postural instability |
| gptkbp:treatment |
gptkb:pharmaceuticals
gptkb:surgery physical therapy maintaining independence improving quality of life symptom management |
| gptkbp:bfsParent |
gptkb:Parkinson's_Foundation
|
| gptkbp:bfsLayer |
7
|